Галерея 3233272

Галерея 3233272
Ai nevoie de contacte corecte ale firmelor ?

Societate comerciala cu raspundere limitata

JUD. GIURGIU, COM. PRUNDU, COM. PRUNDU

JUD. GIURGIU, COM. PRUNDU, COM. PRUNDU

Creeaza cont si verifica imediat informatiile de identificare si datele de facturare pentru orice firma! Ai acces instant la adresa firmei si sediile secundare.

Ai 10 vizualizari direct in contul tau!
Poti verifica nelimitat datele de contact pentru orice firma : Telefoane, Administratori, Adresa de email. Datele sunt validate si actualizate zilnic.
Cifra de afaceri - Medie Industrie 2021

INREGISTRAT din data 15 Februarie 1993

Jud. GIURGIU, Com. PRUNDU - - Prundu

Data inregistrarii ultimei declaratii:(*)

Impozit pe veniturile microintreprinderilor:

Contributia asiguratorie pentru munca:

Contributia asiguratorie de sanatate:

Impozit la titei-gaze nat din prod. interna:

Redevente miniere/Ven. concesiuni si inchirieri:

JUD. GIURGIU, COM. PRUNDU, COM. PRUNDU

Autentifica-te in contul tau RisCo.ro si ai control total in luarea deciziilor!
Acceseaza datele de contact pentru orice companie si cauta clienti noi dupa domeniul de interes.
Vizualizeaza telefoanele, ia legatura cu persoanele de decizie din firma si transmite si o oferta pe email.

Acceseaza peste 8.255.917 telefoane verificate , ia legatura cu 2.349.502 persoane de decizie din cele 756.695 firme active !

16 tipuri de rapoarte bonitate pentru analiza completa si rapida a oricarei firme.

Descopera toate serviciile Risco si activeaza accesul pentru cele care te ajuta in activitate.

Все категории Антиквариат Бизнес и промышленность Билеты Бытовая электронная аппаратура Видеоигры и приставки DVD и фильмы Детские товары Для автолюбителей Здоровье и красота Игрушки и увлечения Изделия из керамики и стекла Искусство Книги Компьютеры/планшетные ПК и сети Куклы и мягкие игрушки Марки Монеты и банкноты Музыка Музыкальные инструменты и оборудование Недвижимость Одежда, обувь и аксессуары Подарочные карты и сертификаты Предметы коллекционирования Разное Реликвии и сувениры Сотовые телефоны и аксессуары Специальные услуги Спорт. сувениры и тов. для болельщиков Спортивные товары Товары для дома и сада Товары для путешествий Товары для рукоделия Товары для ухода за домашними животными Фотоаппараты и видеокамеры Ювелирные украшения и часы
Войдите в систему , чтобы просмотреть свои сведения о пользователе
Произошла ошибка. Чтобы узнать подробнее, посмотрите корзину.
Это объявление было завершено продавцом, так как оно содержало ошибку.

Эта сумма включает соответствующие таможенные пошлины, налоги, оплату услуг, предоставляемых независимой стороной и др. Эта сумма может измениться до момента осуществления платежа. Подробнее см. условия и положения Программы международной доставки - открывается в новом окне или вкладке
Эта сумма включает соответствующие таможенные пошлины, налоги, оплату услуг, предоставляемых независимой стороной и др. Эта сумма может измениться до момента осуществления платежа. Если вы проживаете в государстве, входящем в состав Европейского союза, за исключением Великобритании, импортный НДС, взимаемый при покупке этого товара, не возмещается. Подробнее см. условия и положения Программы международной доставки - открывается в новом окне или вкладке

Без дополнительных импортных сборов при доставке

Подробные сведения о Сделано в Израиле-старинные фотографии 3233309 -

без перевода

Показать исходное объявление о товаре

Приблизительно 981,06 руб. (включая доставку)

Не отправляет товар в страну: Россия

|

См. подробные сведения

imsvintage-lv

( 8234
)

Спонсируемые товары, предлагаемые этим продавцом
Продавец берет на себя полную ответственность за это объявление о товаре.
“These photos emanate from a working newspaper archive thus concede routine physical
imperfections that can include production flaws, hand placed editorial notes, and paste residue. These
details can be seen in the auction photo which shows front and back. Also creasing, border chips and minor
paper loss can occur. View all photos thoroughly prior to bidding.”
Описание товара, предоставленное продавцом
Для получения подробной информации см. Условия возврата eBay открывается в новом окне или в новой вкладке . Если вы получили товар, не соответствующий описанию, на вашу покупку распространяется действие Гарантии возврата денег eBay открывается в новом окне или в новой вкладке .
“ These photos emanate from a working newspaper archive thus concede routine physical
”
Покупатель оплачивает доставку возвращаемого товара

Dashboard
Publications
Account settings
Log out

Journal List

Taylor & Francis Open Select

PMC3233272

Create a new collection

Add to an existing collection

Unable to load your collection due to an error
Please try again

The European Journal of Contraception & Reproductive Health Care
Published online 2011 Nov 8. doi: 10.3109/13625187.2011.604450
* FSHS Kuopio, Kuopio, Finland and MSD, Espoo, Finland
‡ Turun Gynekologikeskus Ky, Turku, Finland
§ Lääkärikeskus Adenova, Espoo, Finland
# Lääkärikeskus Gyneko Oy Oulu, Finland
Correspondence: Ulla Ågren, MD, PhD, MSD, Keilaranta 3 FIN-02150, Espoo, Finland. Tel: + 358 9 804650. Fax:+ 358 9 804 65 431. E-mail: moc.kcrem@nerga.allu
Copyright © 2011 The European Society of Contraception and Reproductive Health
This is an open access article distributed under the Supplemental Terms and Conditions for iOpenAccess articles published in Informa Healthcare journals , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Oral contraceptives, Nomegestrol acetate, Oestradiol, Haemostasis, Lipids, Carbohydrates
** Single most important contraceptive method.
* The Cochran-Mantel-Haenszel test adjusted for age class using standardised midranks, applied on the absolute changes from baseline to cycle 6. A p -value ≤ 0.05 indicates that the difference from baseline to cycle 6 (NOMAC/ E2 vs LNG/EE) was statistically significant.
† The p -value is not presented because > 50% of subjects had D-dimer values below the lower limit of quantification (LLOQ) of 0.22 mg/l FEU.
* The Cochran-Mantel-Haenszel test adjusted for age class using standardised midranks, applied on the absolute changes from baseline to cycle 6. A p -value ≤ 0.05 indicates that the difference from baseline to cycle 6 (NOMAC/ E2 vs LNG/EE) was statistically significant.
* The Cochran-Mantel-Haenszel test adjusted for age class using standardised midranks, applied on the absolute changes from baseline to cycle 6. A p -value ≤ 0.05 indicates that the difference from baseline to cycle 6 (NOMAC/ E2 vs LNG/EE) was statistically significant.
1. United Nations Department of Economic and Social Affairs Population Division. World contraceptive use 2007. Accessed 5 August 2009 from: http://www.un.org/esa/population/publications/contraceptive2007/7contraceptive_2007_table.pdf .
2. Rosenberg MJ, Meyers A, Roy V. Efficacy cycle control, and side effects of low- and lower-dose oral contraceptives: A randomized trial of 20 micrograms and 35 micrograms estrogen preparations. Contraception. 1999; 60 :321–9. [ PubMed ] [ Google Scholar ]
3. Farley TM, Collins J, Schlesselman JJ. Hormonal contraception and risk of cardiovascular disease. An international perspective. Contraception. 1998; 57 :211–30. [ PubMed ] [ Google Scholar ]
4. Blackburn RD, Cunkelman JA, Zlidar VM. Oral contraceptives – an update. In Population Reports, Series A, No. 9, 2000.
5. Szarewski A, Mansour D, Shulman LP. 50 years of'The Pill': Celebrating a golden anniversary. J Fam Plann Reprod Health Care. 2010; 36 :231–8. [ PubMed ] [ Google Scholar ]
6. Lidegaard Ø, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: National follow-up study. BMJ. 2009; 339 :b2890. [ PMC free article ] [ PubMed ] [ Google Scholar ]
7. van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: Results of the MEGA case-control study. BMJ. 2009; 339 :b2921. [ PMC free article ] [ PubMed ] [ Google Scholar ]
8. Reid RL, Westhoff C, Mansour D, et al. Oral contraceptives and venous thromboembolism consensus opinion from an international workshop held in Berlin, Germany in December 2009. J Fam Plann Reprod Health Care. 2010; 36 :117–22. [ PubMed ] [ Google Scholar ]
9. Shapiro S, Dinger J. Risk of venous thromboembolism among users of oral contraceptives: A review of two recently published studies. J Fam Plann Reprod Health Care. 2010; 36 :33–8. [ PubMed ] [ Google Scholar ]
10. Suissa S, Spitzer WO, Rainville B, et al. Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Hum Reprod. 2000; 15 :817–21. [ PubMed ] [ Google Scholar ]
11. Dinger JC, Heinemann LA, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: Final results from the European active surveillance study on oral contraceptives based on 142,475 women-years of observation. Contraception. 2007; 75 :344–54. [ PubMed ] [ Google Scholar ]
12. Hoffmann H, Moore C, Zimmermann H, et al. Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives. Exp Toxicol Pathol. 1998; 50 :458–64. [ PubMed ] [ Google Scholar ]
13. Lello S. Nomegestrol acetate: Pharmacology, safety profile and therapeutic efficacy. Drugs. 2010; 70 :541–59. [ PubMed ] [ Google Scholar ]
14. Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update. 2006; 12 :169–78. [ PubMed ] [ Google Scholar ]
15. Duijkers IJ, Klipping C, Grab P, Korver T. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur J Contracept Reprod Health Care. 2010; 15 :314–25. [ PubMed ] [ Google Scholar ]
16. Christin-Maitre S, Serfary D, Chabbert-Buffet N, et al. Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17(3-estradiol (NOMAC/E2): A double- blind, randomized study. Hum Reprod. 2011; 26 :1338–47. [ PubMed ] [ Google Scholar ]
17. Ågren UM, Anttila M, Mäenpää-Liukko K, et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17p∼oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. Eur J Contracept Reprod Health Care. 2011; 16 :458–67. [ PMC free article ] [ PubMed ] [ Google Scholar ]
18. Committee for Medicinal Products for Human Use. Guideline on clinical investigation of steroid contraceptives in women. In EMEA/CPMP/EWP/519/98 Rev 1, 2005.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18 :499–502. [ PubMed ] [ Google Scholar ]
20. Gerstman BB, Piper JM, Tomita DK, et al. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol. 1991; 133 :32–7. [ PubMed ] [ Google Scholar ]
21. Lidegaard Ø, Edström B, Kreiner S. Oral contraceptives and venous thromboembolism: A five-year national case-control study. Contraception. 2002; 65 :187–96. [ PubMed ] [ Google Scholar ]
22. Jick H, Jick SS, Gurewich V, et al. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995; 346 :1589–93. [ PubMed ] [ Google Scholar ]
23. Spitzer WO, Lewis MA, Heinemann LA, et al. Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study. Transnational research group on oral contraceptives and the health of young women. BMJ. 1996; 312 :83–8. [ PMC free article ] [ PubMed ] [ Google Scholar ]
24. Herings RM, Urquhart J, Leufkens HG. Venous thromboembolism among new users of different oral contraceptives. Lancet. 1999; 354 :127–8. [ PubMed ] [ Google Scholar ]
25. Baillargeon JP, McClish DK, Essah PA, Nestler JE. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis. J Clin Endocrinol Metab. 2005; 90 :3863–70. [ PubMed ] [ Google Scholar ]
26. Lidegaard Ø, Kreiner S. Contraceptives and cerebral thrombosis: A five-year national case-control study. Contraception. 2002; 65 :197–205. [ PubMed ] [ Google Scholar ]
27. Lindberg UB, Crona N, Stigendal L, et al. A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters. Thromb Haemost. 1989; 61 :65–9. [ PubMed ] [ Google Scholar ]
28. Mashchak CA, Lobo RA, Dozono-Takano R, et al. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol. 1982; 144 :511–8. [ PubMed ] [ Google Scholar ]
29. Parke S, Nahum G, Mellinger U, Junge W. Metabolic effects of a new four-phasic oral contraceptive containing estradiol valerate and dienogest. Obstet Gynecol. 2008; 111 (4) Suppl:12S–13S. [ Google Scholar ]
30. Gaussem P, Alhenc-Gelas M, Thomas JL, et al. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17beta-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study. Thromb Haemost. 2011; 105 :560–7. [ PubMed ] [ Google Scholar ]
31. Rosing J, Tans G, Nicolaes GA, et al. Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol. 1997; 97 :233–8. [ PubMed ] [ Google Scholar ]
32. Kemmeren JM, Algra A, Meijers JCM, et al. Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: A randomized trial. Blood. 2004; 103 :927–33. [ PubMed ] [ Google Scholar ]
33. Conard J. Biological coagulation findings in third-generation oral contraceptives. Hum Reprod Update. 1999; 5 :672–80. [ PubMed ] [ Google Scholar ]
34. Tans G, Curvers J, Middeldorp S, et al. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thromb Haemost. 2000; 84 :15–21. [ PubMed ] [ Google Scholar ]
35. de Visser MC, Rosendaal FR, Bertina RM. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood. 1999; 93 :1271–6. [ PubMed ] [ Google Scholar ]
36. Tans G, van Hylckama Vlieg A, Thomassen MC, et al. Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women. Br J Haematol. 2003; 122 :465–70. [ PubMed ] [ Google Scholar ]
37. Godsland IF, Winkler U, Lidegaard Ø, Crook D. Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms. Drugs. 2000; 60 :721–869. [ PubMed ] [ Google Scholar ]
38. Godsland IF. Biology: Risk factor modification by OCs and HRT lipids and lipoproteins. Maturitas. 2004; 47 :299–303. [ PubMed ] [ Google Scholar ]
39. Sitruk-Ware R. Pharmacology of different progestogens: The special case of drospirenone. Climacteric. 2005; 8 (Suppl. 3):4–12. [ PubMed ] [ Google Scholar ]
40. Endrikat J, Klipping C, Cronin M, et al. An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables. Contraception. 2002; 65 :215–21. [ PubMed ] [ Google Scholar ]
41. Scharnagl H, Petersen G, Nauck M, et al. Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism. Contraception. 2004; 69 :105–13. [ PubMed ] [ Google Scholar ]
42. Skouby SO, Endrikat J, Diisterberg B, et al. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel. Contraception. 2005; 71 :111–7. [ PubMed ] [ Google Scholar ]
43. Lopez LM, Grimes DA, Schulz KF. Steroidal contraceptives: Effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database Syst Rev. 2009 CD006133. [ PubMed ] [ Google Scholar ]
44. Brussaard HE, Gevers Leuven JA, Frölich M, et al. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia. 1997; 40 :843–9. [ PubMed ] [ Google Scholar ]
45. Brown MD, Korytkowski MT, Zmuda JM, et al. Insulin sensitivity in postmenopausal women: Independent and combined associations with hormone replacement, cardiovascular fitness, and body composition. Diabetes Care. 2000; 23 :1731–6. [ PubMed ] [ Google Scholar ]
46. Ryan AS, Nicklas BJ, Berman DM. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care. 2002; 25 :127–33. [ PubMed ] [ Google Scholar ]
47. Howard BV, Hsia J, Ouyang P, et al. Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance. Circulation. 2004; 110 :201–6. [ PubMed ] [ Google Scholar ]
48. Os I, Os A, Abdelnoor M, et al. Insulin sensitivity in women with coronary heart disease during hormone replacement therapy. J Womens Health (Larchmt) 2005; 14 :137–45. [ PubMed ] [ Google Scholar ]
49. Bonds DE, Lasser N, Qi L, et al. The effect of conjugated equine oestrogen on diabetes incidence: The women's health initiative randomised trial. Diabetologia. 2006; 49 :459–68. [ PubMed ] [ Google Scholar ]
50. Shadoan MK, Kavanagh K, Zhang L, et al. Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue. Metabolism. 2007; 56 :830–7. [ PubMed ] [ Google Scholar ]
51. Sitruk-Ware R. Progestins and cardiovascular risk markers. Steroids. 2000; 65 :651–8. [ PubMed ] [ Google Scholar ]
52. Cushman M, Arnold AM, Psaty BM, et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: The cardiovascular health study. Circulation. 2005; 112 :25–31. [ PubMed ] [ Google Scholar ]
53. van Rooijen M, Hansson LO, Frostegard J, et al. Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response. J Thromb Haemost. 2006; 4 :77–82. [ PubMed ] [ Google Scholar ]
54. White T, Özel B, Jain JK, Stanczy
Валентина Наппи привычно ебется в анус с неграми
Студентка и пожилой мужик
Грудастая девушка из Малайзии показывает киску

Галерея 3233272

Report Page